Michael Sena examines how manufacturers can navigate the intricacies of strict liability claims, the Federal Hazardous ...

Enliven Therapeutics increased its research and development spending in the fourth quarter of fiscal 2024 as several drug ...

Gogo boosted its year-over-year sales significantly in the fourth quarter of 2024 — a period in which Gogo acquired Satcom Direct — but posted a net loss.